Kestrel Investment Management Corp Invests $5.93 Million in Integer Holdings Corporation $ITGR

Kestrel Investment Management Corp purchased a new position in shares of Integer Holdings Corporation (NYSE:ITGR) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 75,650 shares of the medical equipment provider’s stock, valued at approximately $5,933,000. Integer comprises about 3.4% of Kestrel Investment Management Corp’s holdings, making the stock its 10th largest holding.

A number of other hedge funds have also recently made changes to their positions in ITGR. Salomon & Ludwin LLC boosted its position in shares of Integer by 46.8% during the 4th quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 118 shares during the period. Global Retirement Partners LLC boosted its position in shares of Integer by 293.8% during the 3rd quarter. Global Retirement Partners LLC now owns 319 shares of the medical equipment provider’s stock worth $33,000 after purchasing an additional 238 shares during the period. Farther Finance Advisors LLC boosted its position in shares of Integer by 193.2% during the 4th quarter. Farther Finance Advisors LLC now owns 519 shares of the medical equipment provider’s stock worth $41,000 after purchasing an additional 342 shares during the period. EverSource Wealth Advisors LLC boosted its position in shares of Integer by 210.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 534 shares of the medical equipment provider’s stock worth $66,000 after purchasing an additional 362 shares during the period. Finally, Northwestern Mutual Wealth Management Co. boosted its position in shares of Integer by 861.1% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 692 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 620 shares during the period. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Analyst Ratings Changes

ITGR has been the subject of a number of research analyst reports. Raymond James Financial reaffirmed an “outperform” rating and set a $101.00 price objective on shares of Integer in a research report on Monday, February 23rd. Wall Street Zen cut shares of Integer from a “buy” rating to a “hold” rating in a research report on Sunday, January 25th. Truist Financial increased their price objective on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research report on Friday, February 20th. Citigroup decreased their price target on shares of Integer from $92.00 to $89.00 and set a “neutral” rating for the company in a research report on Friday, May 1st. Finally, Wells Fargo & Company raised their price target on shares of Integer from $72.00 to $84.00 and gave the company an “equal weight” rating in a research report on Friday, February 20th. Four equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, Integer presently has an average rating of “Hold” and a consensus price target of $98.29.

Integer Stock Performance

Shares of ITGR stock opened at $88.15 on Friday. The stock has a market capitalization of $2.99 billion, a PE ratio of 21.98, a P/E/G ratio of 1.52 and a beta of 0.67. The company has a quick ratio of 2.38, a current ratio of 3.75 and a debt-to-equity ratio of 0.77. The firm has a 50 day moving average of $86.12 and a two-hundred day moving average of $81.10. Integer Holdings Corporation has a 52 week low of $62.00 and a 52 week high of $123.78.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.21 by ($0.01). The business had revenue of $439.58 million during the quarter, compared to the consensus estimate of $426.48 million. Integer had a net margin of 7.64% and a return on equity of 12.83%. The company’s quarterly revenue was up .5% compared to the same quarter last year. During the same period last year, the firm earned $1.31 EPS. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. On average, research analysts predict that Integer Holdings Corporation will post 6.11 EPS for the current fiscal year.

Insider Transactions at Integer

In other Integer news, VP Tommy P. Thomas sold 825 shares of the business’s stock in a transaction on Friday, March 13th. The shares were sold at an average price of $85.00, for a total value of $70,125.00. Following the sale, the vice president owned 4,381 shares of the company’s stock, valued at $372,385. The trade was a 15.85% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.10% of the stock is owned by company insiders.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.